A Major Bet on Science Startups Could Shape the UK's Future Economy

Jan de Vries · 2026-09-02

In a move that signals a powerful vote of confidence for the UK's deep tech sector, the British Business Bank has just made a massive commitment. It's putting up to $58.2 million into Zinc Capital Management's second institutional fund, the Science-for-Impact Fund. That's a cornerstone investment, made through their Enterprise Capital Funds program, and it's all about backing entrepreneurs right from day one. Think about it. So many brilliant scientific ideas never make it out of the lab. They get stuck, or fizzle out, because the path from breakthrough to business is incredibly tough. Zinc exists to change that. This pre-seed VC firm, founded in 2017, partners with founders building companies that aim to solve our biggest health and environmental challenges. ### Why This Investment Matters This isn't just about writing a check. It's about fueling a pipeline. The British Business Bank's commitment follows a 2022 investment and will let Zinc expand its support significantly. Mark Sims, Managing Director at the Bank, put it simply: "Breakthrough businesses need support from the very earliest stages if they're to realise their potential." He added, "Zinc has a strong track record of backing founders tackling significant health and environmental challenges... Our commitment to Zinc will help strengthen the pipeline of innovative businesses driving the UK's future economy." That's the real goal here—not just funding one company, but building an entire ecosystem of future-defining businesses. ### How Zinc Turns Science into Impact Zinc's approach is hands-on. They don't just provide capital; they offer what they call "specialist venture-building support." They help founders de-risk the scary part of scientific innovation and accelerate the journey to market. It's a combination of that crucial first investment and practical, expert guidance. Their portfolio gives you a snapshot of the ambition: - **SignaCor**: Developing first-in-class therapeutics for heart disease. - **Epiome**: An AI-powered biomarker platform targeting neurodegenerative diseases. - **Speek**: A digital clinical care platform designed to help teenagers struggling with self-harm. - **Spine**: An AI operating system managing grid-scale battery assets. - **CellMine**: A novel, waste-free process to recycle lithium-ion batteries. ### The Bigger Picture: An $88.5 Million Fund Zinc's Science-for-Impact Fund is targeting a total size of $88.5 million. The plan? To build a portfolio of 80 new DeepTech companies. Ella Goldner, co-founder and Managing Partner at Zinc, highlighted the core problem they're solving: "The UK is home to some of the world's most extraordinary scientific talent, yet too many breakthrough discoveries never become the companies that improve lives, protect our planet and create long-term economic value." She sees this continued partnership with the British Business Bank as proof of a shared belief. Backing ambitious founders early isn't just nice to do—it's "one of the most powerful ways to strengthen the UK's innovation economy." ### What This Means for the Startup Landscape As the largest investor in UK venture capital funds, the British Business Bank plays a unique role. Their cornerstone commitments like this one allow funds to hit their first close faster and execute their strategy more effectively, often at a larger scale. The Enterprise Capital Funds program itself is designed to do two things: increase the supply of equity capital for early-stage UK companies and lower the barriers for entry. So, when you step back, this $58.2 million commitment is more than a headline. It's a strategic investment in a specific future. A future where scientific genius gets the business partnership it needs to thrive. It's a bet that the companies solving our hardest problems—from climate change to chronic disease—can and will be built in the UK. And that's a future worth investing in.